Reviewed by WANGYATAO·Last reviewed 2026-11-11·Medical disclaimer

In short

China's guideline for hypertensive disorders of pregnancy defines pre-eclampsia by organ involvement rather than proteinuria alone, sets blood-pressure targets for pregnancy, and gives exact magnesium sulfate and delivery-timing rules.

What this guide covers: Getting the measurement right · The five categories · Monitoring mother and baby · Treatment · Timing of delivery

Hypertensive disorders complicate a significant share of pregnancies and remain a leading cause of maternal and perinatal serious outcomes. The modern Chinese guideline — the 2025 revision from the Chinese Medical Association, updated with 2026 practice points — restructures the classification around organ involvement and is explicit about when to deliver rather than how long to prolong pregnancy.

Getting the measurement right

Diagnosis starts with proper technique. The guideline specifies a validated device, a cuff whose bladder covers at least 80 percent of the arm circumference and is 40 percent of its width, at least five minutes of seated rest, and two readings at least four hours apart. Hypertension is diagnosed when systolic pressure is 140 mmHg or more, or diastolic 90 mmHg or more on two occasions. A single reading of 160/110 or above is rechecked after 15 minutes rather than four hours.

Proteinuria is best assessed with a random urine protein-to-creatinine ratio of 0.3 g/g or more, or 0.3 g or more over 24 hours.

The five categories

Gestational hypertension is new hypertension after 20 weeks with no proteinuria and no organ involvement, settling within 12 weeks after delivery.

Pre-eclampsia is new hypertension after 20 weeks plus at least one feature of organ involvement: proteinuria, platelets below 100 x 10^9/L, liver transaminases at least twice the upper limit of normal, creatinine above 97 micromol/L or a rise of 26.5 micromol/L, pulmonary oedema, new neurological symptoms such as headache or visual disturbance, or persistent epigastric or right-upper-quadrant pain.

Eclampsia is pre-eclampsia with seizures that have no other explanation. Chronic hypertension with superimposed pre-eclampsia is diagnosed when a woman with chronic hypertension develops new or worsening proteinuria or new organ involvement. Chronic hypertension in pregnancy predates 20 weeks or persists beyond 12 weeks postpartum.

Monitoring mother and baby

Blood pressure is checked at least twice daily, hourly in severe disease. Laboratory monitoring covers full blood count, creatinine, liver enzymes, lactate dehydrogenase and coagulation. Fetal surveillance includes growth scans, amniotic fluid assessment, umbilical artery Doppler, and cardiotocography from around 32 weeks, with frequency driven by stability.

Treatment

Antihypertensive treatment is started at 140/90 mmHg or above in pre-eclampsia and at higher thresholds in gestational hypertension without severe features. The aim is not normalisation: targets are roughly 130 to 155 mmHg systolic and 80 to 105 mmHg diastolic without severe features, and tighter still in severe disease. Labetalol and nifedipine are the preferred oral agents; intravenous labetalol, hydralazine or nicardipine are used for urgent control. Methyldopa is an alternative.

Magnesium sulfate is the key drug that changes outcomes. It is given to prevent seizures in pre-eclampsia with severe features and for the treatment of eclampsia — a loading dose of 4 to 6 g intravenously followed by 1 to 2 g per hour, continued for 24 hours after delivery or after the last seizure.

Timing of delivery

With pre-eclampsia but no severe features, delivery is recommended from 37 weeks. With severe features at or beyond 34 weeks, delivery is indicated. Below 34 weeks, expectant management to 34 weeks is reasonable if mother and fetus are stable, with immediate delivery if blood pressure becomes uncontrollable, platelets fall progressively, liver enzymes rise or the fetus shows distress. After an eclamptic seizure, delivery is planned once the mother is stabilised, generally within two hours.

Mode of delivery follows obstetric indications; caesarean section is not automatic.

After birth and prevention

Blood pressure is monitored closely for the first 48 hours and beyond, magnesium continues for 24 hours, and antihypertensives are continued and then withdrawn as pressure settles. A review at six weeks checks blood pressure, urine protein and renal and liver function, with referral if anything remains abnormal.

For prevention, women at high risk — previous pre-eclampsia, chronic hypertension, diabetes, renal disease, autoimmune disease, multiple pregnancy, BMI of 35 or above — are advised low-dose aspirin from 12 to 16 weeks until delivery. Calcium supplementation of 1.5 to 2 g daily is recommended where baseline intake is low.

Sources and further reading

One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.

General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.